Literature DB >> 10381117

Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France.

L Poirel, A Karim, A Mercat, I Le Thomas, H Vahaboglu, C Richard, P Nordmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381117

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  24 in total

1.  High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea.

Authors:  Dongeun Yong; Jong Hee Shin; Sinyoung Kim; Youngsik Lim; Jong Hwa Yum; Kyungwon Lee; Yunsop Chong; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt.

Authors:  Heba Shehta Said; Abdalbagi Basheer Benmahmod; Ramadan Hassan Ibrahim
Journal:  World J Microbiol Biotechnol       Date:  2018-12-03       Impact factor: 3.312

3.  Biochemical characterization of PER-2 and genetic environment of blaPER-2.

Authors:  Pablo Power; José Di Conza; María Margarita Rodríguez; Bárbara Ghiglione; Juan A Ayala; José María Casellas; Marcela Radice; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

4.  Molecular characteristics and resistant mechanisms of imipenem-resistant Acinetobacter baumannii isolates in Shenyang, China.

Authors:  Jing Ping Zhang; Wan Zhu; Su Fei Tian; Yun Zhuo Chu; Bai Yi Chen
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

5.  Co-production of ESBL and AmpC β-Lactamases in Clinical Isolates of A. baumannii and A. lwoffii in a Tertiary Care Hospital From Northern India.

Authors:  Pooja Singla; Rama Sikka; Antariksh Deeep; Deep Gagneja; Uma Chaudhary
Journal:  J Clin Diagn Res       Date:  2014-04-15

6.  PER-8, a Novel Extended-Spectrum β-Lactamase PER Variant, from an Acinetobacter baumannii Clinical Isolate in Nepal.

Authors:  Tatsuya Tada; Shovita Shrestha; Kayo Shimada; Hiroshi Ohara; Jeevan B Sherchand; Bharat M Pokhrel; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

7.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

8.  Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae.

Authors:  Rémy A Bonnin; Alain A Ocampo-Sosa; Laurent Poirel; Hélène Guet-Revillet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

9.  Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.

Authors:  Sarah M Drawz; Maja Babic; Christopher R Bethel; Magda Taracila; Anne M Distler; Claudia Ori; Emilia Caselli; Fabio Prati; Robert A Bonomo
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

Review 10.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.